Trial Profile
Gut and Azithromycin Mechanisms in Infants and Neonates
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections
- Focus Pharmacodynamics
- Acronyms GAMIN; MORDOR II Burkina Faso
- 24 Mar 2021 Status changed from active, no longer recruiting to completed.
- 28 Feb 2020 Status changed from recruiting to active, no longer recruiting.
- 09 Oct 2019 Planned End Date changed from 1 Aug 2022 to 1 Sep 2022.